Biotechnology in Switzerland

Omne Possibile

Omne Possibile is a pioneering, global technological leader in XNA, creating customizable structures to outperform current DNA and RNA technologies. Its goal is to harness the transformative power of XNA in areas including healthcare, information technology and smart materials. The Company’s initial focus is on development of XNA polymers for information storage and XNA building blocks for improved messenger therapeutics. Omne Possibile has R&D hubs in Leuven, Belgium, and Basel, Switzerland. It was founded by leading European synthetic biologists and is supported by a world class scientific advisory board. For more information, please visit

11 to 50 staff

Mabewo Phytopharm Ag

MABEWO PHYTOPHARM AG arbeitet mit wissenschaftlichem Fokus an der Entwicklung von stabilen Pflanzengenetiken und Herstellungsprozessen nach GACP & GMP für die Herstellung von Phytopharmaka. Zudem wird eine zertifizierte Produktbaureihe im Bereich Anlagentechnik für Verarbeiter im Bereich GACP & GMP, der Pharma-Dome, entwickelt und vermarktet.

1 to 10 staff

Mathis Laboratory Of Adaptive Intelligence

We aim to reverse engineer the neural circuits that drive adaptive motor behavior by studying artificial and natural intelligence. We design behavioral assays for mice, perform large-scale neural recordings, and build new deep learning & machine learning tools to aid in our quest of finding internal models in the brain.

1 to 10 staff

Epfl Igem

Pyronix aims to tackle wildfires. It is a hydrogel designed to fight fires effectively while posing no harm to the environment. This approach shifts fire management from damage control to prevention. Our gel has three main components: cellulose, chitosan, and silica, all biodegradable and environmentally harmless. These components can be extracted from bacteria or yeast, enabling a fully biological supply chain. While our hydrogel can extinguish fires, its primary function is to prevent fire spread by forming firebreaks. It will also enhance firefighting techniques, including counter fires, making them safer without compromising effectiveness.

11 to 50 staff

Biopsomic

Biopsomic is developing a new liquid biopsy for cancer prognosis. From a simple blood draw, our non-invasive test probes the actual disease state and evaluates the risk of developing metastatic disease based on the analysis of nanovesicles called exosomes. These new insights allow oncologists to make proper well-informed clinical decisions and ensure optimal outcomes for patients. We are currently looking for new team members.

1 to 10 staff

Daygnostics Ag

daygnostics commits to delivering solutions for accurate and fast pathogen detection in non-human applications. Our priority is to support industrial partners in providing food of the highest standard and quality to their consumers.

11 to 50 staff

Stc-Science Sàrl

STC science has been founded in 2014 and is located in Switzerland. The idea of this company came from two observations made by biotechnology and healthcare professionals- People in a therapeutic impasse situation will die because of a lack of access to innovative compassionate treatments - To many encouraging and potentially helpful technologies will never reach the market due to the high costs of validation and approval procedures Initially our company focussed on human treatments; we quickly realized that veterinary and environmental extension could be useful. Our network is composed of scientists, engineers and medical doctors with a high level of expertise in their respective field. Aside of STC science’s team, we are permanently growing our network to get access to the right person to answer each question.

1 to 10 staff

Aechem Life Technologies Sàrl

Diagnostics to help patients in their therapeutic journey" Our mission is to revolutionize the diagnostic industry by delivering state-of-the-art technology that sets a new gold standard for accuracy, sensitivity and turn-around time, particularly for the detection of low-concentration biomarkers. We strive to provide high-end yet cost-effective solutions for a broad range of patients via central labs, diagnostic companies and foundations. Ultimately our drive is to improve lives all over the globe, regardless of economic circumstances. Our vision at aeChem is to pioneer the advancement of diagnostic technologies and to be a frontrunner in medical innovation. We believe that as our understanding of disease onset continues to evolve and improve, having diagnostics that can detect low-concentration biomarkers will be more critical than ever. This will enable us to maximize therapeutic effects and improve outcomes - or even survival - for patients. Our technology is ideally positioned to meet this challenge and to bring new and improved diagnostic solutions to the market. As a dynamic and innovative company that is constantly pushing the boundaries of what is possible in the field of diagnostics, our goal is to partner with healthcare professionals worldwide.

1 to 10 staff

Yës-Plus Antibacterial

Antibacterial develope solutions for the industry, MB (PP,PE,ABSPC,ABS.) textile & architecture.

1 to 10 staff

Baxter Bioscience Manufacturing Sàrl

1 to 10 staff